Woodline Partners LP Neurocrine Biosciences Inc Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$130.86 - $143.19 $14.3 Million - $15.6 Million	-109,231 Reduced 88.63%	14,011 $1.93 Million
Q1 2024 May 15, 2024	BUY	$130.4 - $143.74 $2.86 Million - $3.16 Million	21,960 Added 21.68%	123,242 $17 Million
Q4 2023 Feb 14, 2024	SELL	$106.07 - $132.76 $21.4 Million - $26.8 Million	-201,803 Reduced 66.58%	101,282 $13.3 Million
Q3 2023 Nov 14, 2023	SELL	$94.02 - $117.1 $79.8 Million - $99.4 Million	-849,104 Reduced 73.69%	303,085 $34.1 Million
Q2 2023 Aug 14, 2023	BUY	$89.53 - $104.87 $67.5 Million - $79 Million	753,495 Added 188.99%	1,152,189 $109 Million
Q1 2023 May 15, 2023	BUY	$94.11 - $123.02 $8.5 Million - $11.1 Million	90,283 Added 29.27%	398,694 $40.4 Million
Q4 2022 Feb 14, 2023	BUY	$106.72 - $127.06 $32.9 Million - $39.2 Million	308,411 New	308,411 $36.8 Million
Q2 2022 Aug 15, 2022	SELL	$75.79 - $100.07 $19.7 Million - $26 Million	-259,635 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$72.45 - $94.81 $9.56 Million - $12.5 Million	131,992 Added 103.41%	259,635 $24.3 Million
Q4 2021 Feb 14, 2022	SELL	$79.65 - $106.22 $40 Million - $53.3 Million	-502,194 Reduced 79.73%	127,643 $10.9 Million
Q3 2021 Nov 15, 2021	BUY	$86.18 - $99.03 $21.1 Million - $24.2 Million	244,783 Added 63.57%	629,837 $60.4 Million
Q2 2021 Aug 16, 2021	BUY	$89.43 - $102.27 $34.4 Million - $39.4 Million	385,054 New	385,054 $37.5 Million
Q1 2020 May 15, 2020	SELL	$75.11 - $113.76 $5.37 Million - $8.13 Million	-71,496 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$86.8 - $118.57 $6.21 Million - $8.48 Million	71,496 New	71,496 $7.69 Million

Others Institutions Holding NBIX

# of Institutions

626

Shares Held

94M

Call Options Held

632K

Put Options Held

621K

Black Rock Inc. New York, NY

14.2M
Shares

$1.92 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

10M
Shares

$1.35 Billion
0.02% of portfolio
State Street Corp Boston, MA

5.15M
Shares

$697 Million
0.02% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

2.57M
Shares

$349 Million
0.47% of portfolio
Bellevue Group Ag Kuesnacht, V8

1.86M
Shares

$252 Million
3.62% of portfolio

View Full List

About NEUROCRINE BIOSCIENCES INC

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $13B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

More about NBIX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Account